Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Background: Atrial fibrillation is the most frequent cardiac arrhythmia. It has been estimated that 6–12 million people worldwide will suffer this condition in the US by 2050 and 17.9 million people in Europe by 2060. Atrial fibrillation is a major risk factor for ischemic stroke and provokes important economic burden along with significant morbidity and mortality. Aim: We provide here comprehensive and updated statistics on worldwide epidemiology of atrial fibrillation. Methods: An electronic search was conducted for atrial fibrillation. The epidemiologic information was retrieved from the Global Health Data Exchange database, which is regarded as one of the most comprehensive worldwide catalogs of surveys, censuses, vital statistics, and other health-related data. Results: A total of 3.046 million new cases of atrial fibrillation worldwide were registered in the database during 2017. The estimated incidence rate for 2017 (403/millions inhabitants) was 31% higher than the corresponding incidence in 1997. The worldwide prevalence of atrial fibrillation is 37,574 million cases (0.51% of worldwide population), increased also by 33% during the last 20 years. The highest burden is seen in countries with high socio-demographic index, though the largest recent increased occurred in middle socio-demographic index countries. Future projections suggest that absolute atrial fibrillation burden may increase by >60% in 2050. Conclusions: Our analyses suggest that atrial fibrillation incidence and prevalence have increased over the last 20 years and will continue to increase over the next 30 years, especially in countries with middle socio-demographic index, becoming one of the largest epidemics and public health challenges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Krijthe, B. P., Kunst, A., Benjamin, E. J., Lip, G. Y. H., Franco, O. H., Hofman, A., Witteman, J. C. M., Stricker, B. H., & Heeringa, J. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht280 · Cited by 1,419
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., Ferguson, T. B., Ford, E., Furie, K., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192666 · Cited by 1,359
Epidemiology of atrial fibrillation: European perspective
Zoni-Berisso, M., Lercari, F., Carazza, T., & Domenicucci, S. (2014) · Clinical Epidemiology · doi:10.2147/clep.s47385 · Cited by 1,273
Modifiable Risk Factors and Atrial Fibrillation
Lau, D. H., Nattel, S., Kalman, J. M., & Sanders, P. (2017) · Circulation · doi:10.1161/circulationaha.116.023163 · Cited by 593
Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration
Freedman, B., Camm, J., Calkins, H., Healey, J. S., Rosenqvist, M., Wang, J., Albert, C. M., Anderson, C. S., Antoniou, S., Benjamin, E. J., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026693 · Cited by 537
Patel, N. J., Deshmukh, A., Pant, S., Singh, V., Patel, N., Arora, S., Shah, N., Chothani, A., Savani, G. T., Mehta, K., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.008201 · Cited by 429
Lip, G. Y. H., Freedman, B., De Caterina, R., & Potpara, T. S. (2017) · Thrombosis and Haemostasis · doi:10.1160/th16-11-0876 · Cited by 400
Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients
Wilke, T., Groth, A., Mueller, S., Pfannkuche, M., Verheyen, F., Linder, R., Maywald, U., Bauersachs, R., & Breithardt, G. (2013) · Europace · doi:10.1093/europace/eus333 · Cited by 397 · cited 1×
“Our results confirm that worldwide incidence and prevalence of AF show an increasing trend, which can be even sharper than expected in previous reports.(13,14) Likewise, we also confirmed that men suffer from AF more often than women, and that the worldwide burden of AF (in terms of DALYs or mortality) is the highest…”
ResultGlobal Burden of Atrial Fibrillation in Developed and Developing Nations
Chugh, S. S., Roth, G. A., Gillum, R. F., & Mensah, G. A. (2014) · Global Heart · doi:10.1016/j.gheart.2014.01.004 · Cited by 253
Mairesse, G. H., Moran, P., Van Gelder, I. C., Elsner, C., Rosenqvist, M., Mant, J., Banerjee, A., Gorenek, B., Brachmann, J., Varma, N., et al. (2017) · EP Europace · doi:10.1093/europace/eux177 · Cited by 250
Gorenek, B., Bax, J., Boriani, G., Chen, S.-A., Dagres, N., Glotzer, T. V., Healey, J. S., Israel, C. W., Kudaiberdieva, G., Levin, L.-Å., et al. (2017) · EP Europace · doi:10.1093/europace/eux163 · Cited by 247
Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections
Stefansdottir, H., Aspelund, T., Gudnason, V., & Arnar, D. O. (2011) · EP Europace · doi:10.1093/europace/eur132 · Cited by 182
Allan, V., Honarbakhsh, S., Casas, J.-P., Wallace, J., Hunter, R., Schilling, R., Perel, P., Morley, K., Banerjee, A., & Hemingway, H. (2017) · Thrombosis and Haemostasis · doi:10.1160/th16-11-0825 · Cited by 176
Görenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J. G. M., Fogel, R. I., Gelder, I. C. V., Halle, M., Kudaiberdieva, G., Lane, D. A., et al. (2016) · EP Europace · doi:10.1093/europace/euw242 · Cited by 154
Atrial fibrillation in highly trained endurance athletes — Description of a syndrome
Sanchis-Gomar, F., Perez-Quilis, C., Lippi, G., Cervellin, G., Leischik, R., Löllgen, H., Serrano-Ostáriz, E., & Lucia, A. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.10.047 · Cited by 95
Self-citationEffectiveness of screening for atrial fibrillation and its determinants. A meta-analysis
Petryszyn, P. W., Niewiński, P., Staniak, A., Piotrowski, P., Well, A., Well, M., Jęśkowiak, I., Lip, G. Y. H., & Ponikowski, P. P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213198 · Cited by 65
Adderley, N. J., Nirantharakumar, K., & Marshall, T. P. (2018) · BMJ · doi:10.1136/bmj.k1717 · Cited by 58
Börschel, C. S., & Schnabel, R. B. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.11.123 · Cited by 58
Ahmad, Y., Lip, G. Y. H., & Lane, D. A. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.03.009 · Cited by 38
A Contemporary Review on the Genetic Basis of Atrial Fibrillation
Roberts, J. D., & Gollob, M. H. (2014) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-10-1-18 · Cited by 25
Should we screen for atrial fibrillation?
Lown, M. T., & Moran, P. S. (2019) · BMJ · doi:10.1136/bmj.l43 · Cited by 22
Stroke prevention in atrial fibrillation: State of the art
Li, Y., & Lip, G. Y. H. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.09.057 · Cited by 21
Deshpande, S., Catanzaro, J. N., & Wann, S. (2014) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2013.10.006 · Cited by 13
Cited by
Van Gelder, I. C., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., De Potter, T. J. R., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,024
Brundel, B. J. J. M., Ai, X., Hills, M. T., Kuipers, M. F., Lip, G. Y. H., & de Groot, N. M. S. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00347-9 · Cited by 499
Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database
Kaur, R., Dutta, S., Charan, J., Bhardwaj, P., Tandon, A., Yadav, D., Islam, S., & Haque, M. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s324349 · Cited by 125
The role of the blood–brain barrier during neurological disease and infection
Patabendige, A., & Janigro, D. (2023) · Biochemical Society Transactions · doi:10.1042/bst20220830 · Cited by 112
Racial and Ethnic Considerations in Patients With Atrial Fibrillation
Norby, F. L., Benjamin, E. J., Alonso, A., & Chugh, S. S. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.110 · Cited by 46
Metadata
- Authors
- Lippi, G., Sanchis-Gomar, F., & Cervellin, G.
- Venue
- International Journal of Stroke
- Publisher
- SAGE Publications
- Published
- 2020-01-19
- Volume
- 16
- Issue
- 2
- Pages
- 217-221
- ISSN
- 1747-4930 (ISSN-L)
- 1747-4949
- OpenAlex
- W3000776376
- Cited by
- 1,437
- References
- 24
- FWCI
- 87.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.